Citations (143)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Chi-Lun Tsai, Chih-Cheng Lai, Ching-Yi Chen & Ho-Sheng Lee. (2023) The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy 21:1, pages 77-86.
Read now
Read now
Hongbo Jiang, Qiaosen Chen, Shaoping Zheng, Chunxia Guo, Jinzhuo Luo, Hua Wang, Xin Zheng & Zhihong Weng. (2022) Association of Complement C3 with Clinical Deterioration Among Hospitalized Patients with COVID-19. International Journal of General Medicine 15, pages 849-857.
Read now
Read now
Bushra Mdkhana, Narjes Saheb Sharif-Askari, Rakhee K Ramakrishnan, Swati Goel, Qutayba Hamid & Rabih Halwani. (2021) Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality. Journal of Inflammation Research 14, pages 199-216.
Read now
Read now
Sisay Getu, Tegenaw Tiruneh, Henok Andualem, Wasihun Hailemichael, Teklehayimanot Kiros, Demeke Mesfin Belay & Mulugeta Kiros. (2021) Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19. Journal of Blood Medicine 12, pages 635-643.
Read now
Read now
Christos Varelas, Athina Tampaki, Ioanna Sakellari, Αchilles Anagnostopoulos, Eleni Gavriilaki & Efthymia Vlachaki. (2021) Complement in Sickle Cell Disease: Are We Ready for Prime Time?. Journal of Blood Medicine 12, pages 177-187.
Read now
Read now
Sofiane Fodil & Djillali Annane. (2021) Complement Inhibition and COVID-19: The Story so Far. ImmunoTargets and Therapy 10, pages 273-284.
Read now
Read now
Chenghai Li, Hua Zhao, Linna Cheng & Bin Wang. (2021) Anti-Inflammation, Immunomodulation and Therapeutic Repair in Current Clinical Trials for the Management of COVID-19. Drug Design, Development and Therapy 15, pages 1345-1356.
Read now
Read now
Shreya R. Savla, Kedar S. Prabhavalkar & Lokesh K. Bhatt. (2021) Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management. Expert Review of Anti-infective Therapy 19:11, pages 1397-1413.
Read now
Read now
Maria Alice V. Willrich, Karin M. P. Braun, Ann M. Moyer, David H. Jeffrey & Ashley Frazer-Abel. (2021) Complement testing in the clinical laboratory. Critical Reviews in Clinical Laboratory Sciences 58:7, pages 447-478.
Read now
Read now
Alexis Genthon, Thibault Chiarabini, Pierre Baylac, Nadia Valin, Tomas Urbina, Jérome Pacanowski, Arsène Mekinian, Eolia Brissot, Fella M.’Hammedi-Bouzina, Simona Lapusan, Mohamad Mohty, Karine Lacombe & Patrick Ingiliz. (2021) Severe COVID-19 infection in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab therapy. Leukemia & Lymphoma 62:6, pages 1502-1505.
Read now
Read now
Deniz Cagdas. (2021) Convalescent plasma and hyperimmune globulin therapy in COVID-19. Expert Review of Clinical Immunology 17:4, pages 309-315.
Read now
Read now
Marco Giuseppe Migliaccio, Marco Di Mauro, Riccardo Ricciolino, Giorgio Spiniello, Vincenzo Carfora, Nicoletta Verde, Filiberto Fausto Mottola & Nicola Coppola. (2021) Renal Involvement in COVID-19: A Review of the Literature. Infection and Drug Resistance 14, pages 895-903.
Read now
Read now
Sojit Tomo, Kiran Pvsn Kumar, Dipayan Roy, Shrimanjunath Sankanagoudar, Purvi Purohit, Dharamveer Yadav, Mithu Banerjee, Praveen Sharma & Sanjeev Misra. (2021) Complement activation and coagulopathy - an ominous duo in COVID19. Expert Review of Hematology 14:2, pages 155-173.
Read now
Read now
Sherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, Ehab Shaker, Mona A F Nada, Sandra M Ahmed, Mohamed I Hegazy, Husam S Mourad, Ahmed Abdelalim, Rehab Magdy, Alshimaa S Othman, Doaa A Mekkawy & Nirmeen A Kishk. (2020) Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era. Therapeutics and Clinical Risk Management 16, pages 759-767.
Read now
Read now
Cléa Melenotte, Aymeric Silvin, Anne-Gaëlle Goubet, Imran Lahmar, Agathe Dubuisson, Alimuddin Zumla, Didier Raoult, Mansouria Merad, Bertrand Gachot, Clémence Hénon, Eric Solary, Michaela Fontenay, Fabrice André, Markus Maeurer, Giuseppe Ippolito, Mauro Piacentini, Fu-Sheng Wang, Florent Ginhoux, Aurélien Marabelle, Guido Kroemer, Lisa Derosa & Laurence Zitvogel. (2020) Immune responses during COVID-19 infection. OncoImmunology 9:1.
Read now
Read now
Articles from other publishers (128)
Mark T. Xiao, Calder R. Ellsworth & Xuebin Qin. (2024) Emerging role of complement in COVID-19 and other respiratory virus diseases. Cellular and Molecular Life Sciences 81:1.
Crossref
Crossref
M. G. Detsika, K. Palamaris, I. Dimopoulou, A. Kotanidou & S. E. Orfanos. (2024) The complement cascade in lung injury and disease. Respiratory Research 25:1.
Crossref
Crossref
Frances C Hall, Joseph Cheriyan, Andrew P Cope, James Galloway, Ian Wilkinson, Simon Bond, Sam Norton, Edward Banham-Hall, Hannah Bayes, Michalis Kostapanos, Marianna Nodale, William G Petchey, Thomas Sheeran, Jonathan Underwood, David R Jayne, Frances C Hall, Joseph Cheriyan, Andrew P Cope, James Galloway, Ian Wilkinson, Simon Bond, Sam Norton, Edward Banham-Hall, Hannah Bayes, Michalis Kostapanos, Marianna Nodale, William Petchey, Thomas Sheeran, Jonathan Underwood, David R Jayne, James Galloway, Deepak Nagra, Sam Norton, Georgina Bird, Jonathan Underwood, Rhys John Davies, Donall Forde, Clemency Nye, Andrea Balan, Sam Bird, Vianne Britten, Lauren Broad, Teriann Evans, Sharon Frayling, Laura Gray, Matthew Haynes, Catherine Oliver, Karen Rahilly, Gail Williams, Tanwir Ahmed, Carrie Bayliss, Natalie Byrne, Elena Hernan-Sancho, Mary Kasanicki, Louise Stockley, Heike Templin, Michalis Kostapanos, Joseph Cheriyan, Edward Banham-Hall, Marie Fisk, James Goodman, Johann Graggaber, Joanna Gray, Tania Gudu, Spoorthy Kulkarni, Ing Ni Lu, Peta Masters, Fraz Mir, Carmel Stober, Donna Abercrombie, Areti Bermperi, Stella Burns, Laura Canna, Jason Domingo, Kathy Hodges, Sherly Jose, Evgenia Kourampa, Anne Meadows, Vivien Mendoza, Thelma Mushapaizdi, Aileen Nacorda, Ciro Pasquale, Debbie Read, Jane Rowlands, Valentina Ruffulo, Carlotta Soave, Lissamma Titti, Hugo Tordesillas, Samantha Wright, Hannah Bayes, Kathryn Scott, Varun Sharma, Susanne Cathcart, Dominic Rimmer, Gary Semple, Tom Sheeran, Laurence Phiri, Ann Plumbe, William Petchey, Shweta Bhagat, Anne Margaret Moody, Jo Kellett, Marwan Bukhari, Karen Burns, Susanna Crayton, Andra Fielding, Kerry Simpson, Andrew Shah, Hilary Thatcher, Damodar Makkuni, Wendy Harrison, Thrusha Jain, Jean Patrick, Arthur Pratt, Neil S Sheerin, David Kavanagh, Andrew Barr, Kelly Baldwin, Claire Judd, Paul McAlinden, Louise McCormack, Elaine Stephenson, Sunil Sharma, Elizabeth L A Cross, Kirsty Bracewell, Monika Musiol, Matthew Seal, Andrew Cope, Gouri Koduri, Mihaela Mercioniu, Swapna Kunhunny, Louise Pollard, Gerald Coakley, Sunil Gupta, Amelia Holloway, Samia Pilgrim, Estefania Treus, Gabriele Boehmer, Eva Beranova, Ana Ionita, Louise Allen, Joanne Deery, Tracy Hazelton, Alicia Knight, Carly Price, Sorrell Tilbey, Charlotte Bradbury, Joanna Willis, Kay Drury, Daniel Putensen, Anja Schmidtmann, James Galloway, Georgios K Dimitraidis, Sukanya Gogoi, Jennifer Vidler, Nicola Griffiths, Arvind Rajasekaran, Amy Orme, Debbie Devenport, Muhammad Nisar, Andrew Ustianowski, Gabriella Lindergard, Alison Uriel, Samuel Hey, Thomas Lamb, Michelle Bruce, Jan Flaherty, Claire Fox, Helen Parfrey & Kane Dorey. (2023) Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial. The Lancet Respiratory Medicine 11:12, pages 1064-1074.
Crossref
Crossref
Djillali Annane, Sean J Pittock, Hrishikesh S Kulkarni, Brian W Pickering, Matt R Khoshnevis, Jason L Siegel, Charles A Powell, Pedro Castro, Tomoko Fujii, Derek Dunn, Keisha Smith, Sanjay Mitter, Shamsah Kazani & Austin Kulasekararaj. (2023) Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial. The Lancet Respiratory Medicine 11:12, pages 1051-1063.
Crossref
Crossref
Xiaowen Ge, Zhui Yu, Xinxin Guo, Ling Li, Ling Ye, Maosong Ye, Jingping Yuan, Chouwen Zhu, Weiguo Hu & Yingyong Hou. (2023) Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients. Pathology - Research and Practice 247, pages 154519.
Crossref
Crossref
Mengdi Li, Xiaoming Wu, Jialan Shi & Yumei Niu. (2023) Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes. Endocrine 82:1, pages 15-27.
Crossref
Crossref
Bruna M. Silva, Giovanni F. Gomes, Flavio P. Veras, Seppe Cambier, Gabriel V.L. Silva, Andreza U. Quadros, Diego B. Caetité, Daniele C. Nascimento, Camilla M. Silva, Juliana C. Silva, Samara Damasceno, Ayda H. Schneider, Fabio Beretta, Sabrina S. Batah, Icaro M.S. Castro, Isadora M. Paiva, Tamara Rodrigues, Ana Salina, Ronaldo Martins, Guilherme C.M. Cebinelli, Naira L. Bibo, Daniel M. Jorge, Helder I. Nakaya, Dario S. Zamboni, Luiz O. Leiria, Alexandre T. Fabro, José C. Alves-Filho, Eurico Arruda, Paulo Louzada-Junior, Renê D. Oliveira, Larissa D. Cunha, Pierre Van Mol, Lore Vanderbeke, Simon Feys, Els Wauters, Laura Brandolini, Andrea Aramini, Fernando Q. Cunha, Jörg Köhl, Marcello Allegretti, Diether Lambrechts, Joost Wauters, Paul Proost & Thiago M. Cunha. (2023) C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps. Journal of Clinical Investigation 133:12.
Crossref
Crossref
Parastoo Yousefi, Saber Soltani, Goli Siri, Sara Akhavan Rezayat, Ali Gholami, Alireza Zafarani, Mohamad Hossein Razizadeh, Ehsan Alborzi, Golnaz Mokhtary‐Irani, Behnam Abedi, Sajad Karampoor, Alireza Tabibzadeh & Abbas Farahani. (2023) Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review. Journal of Clinical Laboratory Analysis 37:11-12.
Crossref
Crossref
Xiaoqin Wei, Harish Narasimhan, Bibo Zhu & Jie Sun. (2023) Host Recovery from Respiratory Viral Infection. Annual Review of Immunology 41:1, pages 277-300.
Crossref
Crossref
Prabhat K. Purbey, Koushik Roy, Sandeep Gupta & Manash K. Paul. (2023) Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2. Molecular Immunology 156, pages 111-126.
Crossref
Crossref
Anuradha Rajamanickam, Pavan Kumar Nathella, Aishwarya Venkataraman, Bindu Dasan, Sulochana Putlibai, Shaik Fayaz Ahamed, Nandhini Selvaraj, Kalaimaran Sadasivam, Balasubramanian Sundaram, Thomas B. Nutman & Subash Babu. (2023) Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome. JAMA Network Open 6:3, pages e231713.
Crossref
Crossref
Guiling Chen, Nan Li, Xiahong Dai, Shiyan Tu, Zhenwei Shen, Kaiqi Wu, Tinghan Jin, Jiajun Wu, Conggao Peng, Guoping Sheng, Mengfei Zhu, Lingling Tang & Lanjuan Li. (2023) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults. Infectious Diseases and Therapy 12:2, pages 663-675.
Crossref
Crossref
Nasibeh Zerangian, Gisou Erabi, Mohadeseh Poudineh, Kosar Monajjem, Maryam Diyanati, Maryam Khanlari, Amirmohammad Khalaji, Diba Allafi, Arezoo Faridzadeh, Arian Amali, Nilufar Alizadeh, Yasaman Salimi, Sajjad Ghane Ezabadi, Amir Abdi, Zahra Hasanabadi, Mahdie ShojaeiBaghini & Niloofar Deravi. (2023) Venous thromboembolism in viral diseases: A comprehensive literature review. Health Science Reports 6:2.
Crossref
Crossref
Chandrima Gain, Sihyeong Song, Tyler Angtuaco, Sandro Satta & Theodoros Kelesidis. (2023) The role of oxidative stress in the pathogenesis of infections with coronaviruses. Frontiers in Microbiology 13.
Crossref
Crossref
Ali Zhang, Hannah D. Stacey, Michael R. D’Agostino, Yona Tugg, Art Marzok & Matthew S. Miller. (2022) Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection. Nature Reviews Immunology.
Crossref
Crossref
Pascal Urwyler, Stephan Moser, Marten Trendelenburg, Parham Sendi & Michael Osthoff. (2022) Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression. Molecular Immunology 150, pages 99-113.
Crossref
Crossref
Lijie Jiang, Fanglian Yao, Ershuai Zhang, Qingyu Yu, Chaojie Yu, Ze Chen, Jing Chen, Zhiwei Yue, Pengcheng Che, Junjie Li & Hong Sun. (2022) Combined treatment of xyloglucan derivative hydrogel and anti-C5a receptor antibody in preventing peritoneal adhesion. Acta Biomaterialia 151, pages 163-173.
Crossref
Crossref
Ting Gao, Lin Zhu, Hainan Liu, Xiaopeng Zhang, Tingting Wang, Yangbo Fu, Hongzhen Li, Qincai Dong, Yong Hu, Zhang Zhang, Jing Jin, Zijing Liu, Weihong Yang, Yaoning Liu, Yanwen Jin, Kaitong Li, Yongjiu Xiao, Junli Liu, Huailong Zhao, Yue Liu, Ping Li, Jibo Song, Lu Zhang, Yuwei Gao, Sisi Kang, Shoudeng Chen, Qingjun Ma, Xiuwu Bian, Wei Chen, Xuan Liu, Qing Mao & Cheng Cao. (2022) Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Hongbo Chi, Kai Zhou, Liping Shen, Jiaqin Xu, Jun Li, Shiyong Chen, Xiaomai Wu, Tao-Hsin Tung, Bo Shen & Hongguo Zhu. (2022) The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: A longitudinal cohort study. International Immunopharmacology 110, pages 109019.
Crossref
Crossref
Tzuriel Sapir, Zaelig Averch, Brian Lerman, Abraham Bodzin, Yeshaya Fishman & Radhashree Maitra. (2022) COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. International Journal of Molecular Sciences 23:15, pages 8606.
Crossref
Crossref
Panagiota Gianni, Mark Goldin, Sam Ngu, Stefanos Zafeiropoulos, Georgios Geropoulos & Dimitrios Giannis. (2022) Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review. World Journal of Experimental Medicine 12:4, pages 53-67.
Crossref
Crossref
Victoria A. Mañón, Steven Balandran, Simon Young, Mark Wong & James C. Melville. (2022) COVID-Associated Avascular Necrosis of the Maxilla—A Rare, New Side Effect of COVID-19. Journal of Oral and Maxillofacial Surgery 80:7, pages 1254-1259.
Crossref
Crossref
Eleni Gavriilaki, Stefanos A. Tsiftsoglou, Tasoula Touloumenidou, Evangelia Farmaki, Paraskevi Panagopoulou, Elissavet Michailidou, Evaggelia-Evdoxia Koravou, Ioulia Mavrikou, Elias Iosifidis, Olga Tsiatsiou, Eleni Papadimitriou, Efimia Papadopoulou-Alataki, Penelope Georgia Papayanni, Christos Varelas, Styliani Kokkoris, Apostolia Papalexandri, Maria Fotoulaki, Assimina Galli-Tsinopoulou, Dimitrios Zafeiriou, Emmanuel Roilides, Ioanna Sakellari, Achilles Anagnostopoulos & Athanasios Tragiannidis. (2022) Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection. Current Issues in Molecular Biology 44:7, pages 2811-2824.
Crossref
Crossref
Hanmant Gaikwad, Yue Li, Guankui Wang, Ronghui Li, Shaodong Dai, Cody Rester, Ross Kedl, Laura Saba, Nirmal K. Banda, Robert I. Scheinman, Casey Patrick, Krishna M.G. Mallela, S. Moein Moghimi & Dmitri Simberg. (2022) Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles. ACS Nano 16:6, pages 8704-8715.
Crossref
Crossref
Robert V. House, Thomas A. Broge, Todd J. Suscovich, Doris M. Snow, Milan T. Tomic, Genevieve Nonet, Kamaljit Bajwa, Guangyu Zhu, Zachary Martinez, Kyal Hackett, Christopher G. Earnhart, Nicole M. Dorsey, Svetlana A. Hopkins, Dalia S. Natour, Heather D. Davis, Michael S. Anderson, Melicia R. Gainey & Ronald R. Cobb. (2022) Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. PLOS ONE 17:6, pages e0267796.
Crossref
Crossref
Pedro Castro, Marta Palomo, Ana Belen Moreno-Castaño, Sara Fernández, Sergi Torramadé-Moix, Georgina Pascual, Julia Martinez-Sanchez, Edward Richardson, Adrián Téllez, Josep M. Nicolas, Enric Carreras, Paul G. Richardson, Juan José Badimon, Gines Escolar & Maribel Diaz-Ricart. (2021) Is the Endothelium the Missing Link in the Pathophysiology and Treatment of COVID-19 Complications?. Cardiovascular Drugs and Therapy 36:3, pages 547-560.
Crossref
Crossref
Giuseppe Pignataro, Mauro Cataldi & Maurizio Taglialatela. (2021) Neurological risks and benefits of cytokine‐based treatments in coronavirus disease 2019: from preclinical to clinical evidence. British Journal of Pharmacology 179:10, pages 2149-2174.
Crossref
Crossref
Yingying Fang, Yan Guo, Tongtong Gao, Xuelian Han, Yuting Jiang, Min Li, Wei Xue, Binhui Yang, Yujun Cui, Shihui Sun & Guangyu Zhao. (2022) A Dual Role of Complement Activation in the Development of Fulminant Hepatic Failure Induced by Murine-Beta-Coronavirus Infection. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Jack Mellors, Tom Tipton, Sarah Katharina Fehling, Joseph Akoi Bore, Fara Raymond Koundouno, Yper Hall, Jacob Hudson, Frances Alexander, Stephanie Longet, Stephen Taylor, Andrew Gorringe, N’Faly Magassouba, Mandy Kader Konde, Julian Hiscox, Thomas Strecker & Miles Carroll. (2022) Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis. Frontiers in Immunology 13.
Crossref
Crossref
Firdos Ahmad, Meganathan Kannan & Abdul W. Ansari. (2022) Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine & Growth Factor Reviews 63, pages 58-68.
Crossref
Crossref
Ewa Ostrycharz & Beata Hukowska-Szematowicz. (2022) New Insights into the Role of the Complement System in Human Viral Diseases. Biomolecules 12:2, pages 226.
Crossref
Crossref
Abdelmohcine Aimrane, Bilal El-Mansoury, Said Sabir, Soraia El Baz, Nadia Zouhairi, Mohamed Echchakery, Ahmed Draoui, Chatoui Hicham, Naima Fdil, Souad Sellami, Abdesslam Ferssiwi, Abdelali Bitar & Hanane Rais. 2022. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19. Handbook of Research on Pathophysiology and Strategies for the Management of COVID-19
159
175
.
ANTÔNIO V.B. DA SILVA, JOÃO DE A.G. CAMPANATI, ISADORA DE S. BARCELOS, ALBERTO C.L. SANTOS, UILDSON P. DE DEUS, TELMA DE J. SOARES & LILIANY S. DE B. AMARAL. (2022) COVID-19 and Acute Kidney Injury ― Direct and Indirect Pathophysiological Mechanisms Underlying Lesion Development. Anais da Academia Brasileira de Ciências 94:suppl 3.
Crossref
Crossref
Raza Ali Naqvi, Deepak Shukla & Afsar R. Naqvi. (2021) SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment. Immunity, Inflammation and Disease 10:1, pages 22-25.
Crossref
Crossref
Henry H. L. Wu, Mohan Shenoy, Philip A. Kalra & Rajkumar Chinnadurai. (2021) Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review. Children 9:1, pages 3.
Crossref
Crossref
Piero Ruggenenti, Fabiano Di Marco, Monica Cortinovis, Luca Lorini, Silvia Sala, Luca Novelli, Federico Raimondi, Sara Gastoldi, Miriam Galbusera, Roberta Donadelli, Caterina Mele, Rossella Piras, Marina Noris, Valentina Portalupi, Laura Cappelletti, Camillo Carrara, Federica Tomatis, Silvia Bernardi, Annalisa Perna, Tobia Peracchi, Olimpia Diadei, Ariela Benigni & Giuseppe Remuzzi. (2021) Eculizumab in patients with severe coronavirus disease 2019 (COVID-19) requiring continuous positive airway pressure ventilator support: Retrospective cohort study. PLOS ONE 16:12, pages e0261113.
Crossref
Crossref
Farhan S. Cyprian, Muhammad Suleman, Ibrahim Abdelhafez, Asmma Doudin, Ibn Mohammed Masud Danjuma, Fayaz Ahmad Mir, Aijaz Parray, Zohaib Yousaf, Mohammed Yaseen Ahmed Siddiqui, Alaaedin Abdelmajid, Mohammad Mulhim, Shaikha Al-Shokri, Mohammad Abukhattab, Ranad Shaheen, Eyad Elkord, Abdul Latif Al-khal, Abdel-Naser Elzouki & Guillermina Girardi. (2021) Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population. Frontiers in Immunology 12.
Crossref
Crossref
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang & Kapaettu Satyamoorthy. (2021) Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. Journal of Ovarian Research 14:1.
Crossref
Crossref
Yadong Fan, Ying Wang, Shuang Yu, Jun Chang, Yiqi Yan, Yiyang Wang & Yuhong Bian. (2021) Natural products provide a new perspective for anti-complement treatment of severe COVID-19: a review. Chinese Medicine 16:1.
Crossref
Crossref
Parminder Kaur, Firas Qaqa, Amr Ramahi, Yezin Shamoon, Monisha Singhal, Fayez Shamoon, Michael Maroules & Balraj Singh. (2021) Acute upper limb ischemia in a patient with COVID-19. Hematology/Oncology and Stem Cell Therapy 14:4, pages 348-350.
Crossref
Crossref
Ming Sheng Lim & Simon Mcrae. (2021) COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Critical Reviews in Oncology/Hematology 168, pages 103529.
Crossref
Crossref
Fatemeh Keshavarz, Farideh Ghalamfarsa, Saeed Javdansirat, Sajad Hasanzadeh, Arsalan Azizi, Gholamabbas Sabz, Marziyeh Salehi & Ghasem Ghalamfarsa. (2021) Patients with Covid 19 have significantly reduced CH50 activity. VirusDisease 32:4, pages 681-689.
Crossref
Crossref
Silke Huber, Mariam Massri, Marco Grasse, Verena Fleischer, Sára Kellnerová, Verena Harpf, Ludwig Knabl, Ludwig KnablSr.Sr., Tatjana Heiner, Moritz Kummann, Magdalena Neurauter, Günter Rambach, Cornelia Speth & Reinhard Würzner. (2021) Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections. Viruses 13:12, pages 2376.
Crossref
Crossref
Lily Chan, Negar Karimi, Solmaz Morovati, Kasra Alizadeh, Julia E. Kakish, Sierra Vanderkamp, Fatemeh Fazel, Christina Napoleoni, Kimia Alizadeh, Yeganeh Mehrani, Jessica A. Minott, Byram W. Bridle & Khalil Karimi. (2021) The Roles of Neutrophils in Cytokine Storms. Viruses 13:11, pages 2318.
Crossref
Crossref
Yaiza Senent, Susana Inogés, Ascensión López-Díaz de Cerio, Andres Blanco, Arantxa Campo, Francisco Carmona-Torre, Patricia Sunsundegui, Antonio González-Martín, Daniel Ajona, Marcin Okrój, Felipe Prósper, Ruben Pio, José Ramón Yuste & Beatriz Tavira. (2021) Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge. Frontiers in Immunology 12.
Crossref
Crossref
E. V. Sluhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. S. Shkoda, O. P. Artyukov, V. I. Tsibizova, A. L. Mishchenko, K. N. Grigorieva, J.-С. Gris, E. Elalamy & A. D. Makatsariya. (2021) COVID-19 and thrombotic microangiopathy. Obstetrics, Gynecology and Reproduction 15:6, pages 639-657.
Crossref
Crossref
Sara Tomerak, Safah Khan, Muna Almasri, Rawan Hussein, Ali Abdelati, Ahmed Aly, Mohammad A. Salameh, Arwa Saed Aldien, Hiba Naveed, Mohamed B. Elshazly & Dalia Zakaria. (2021) Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scandinavian Journal of Immunology 94:5.
Crossref
Crossref
Yuting Jiang, Yuehong Chen, Hong Sun, Xiaolu Zhang, Lei He, Jiangfan Li, Guangyu Zhao & Shihui Sun. (2021) MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation. Journal of General Virology 102:10.
Crossref
Crossref
Tobias Zrzavy, Isabella Wimmer, Paulus S. Rommer & Thomas Berger. (2020) Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown. European Journal of Neurology 28:10, pages 3503-3516.
Crossref
Crossref
Maaweya E. Hamed, Asif Naeem, Haitham Alkadi, Aref A. Alamri, Ahmad S. AlYami, Abdullah AlJuryyan, Wael Alturaiki, Mushira Enani, Samia T. Al-Shouli, Abdullah M. Assiri & Bandar Alosaimi. (2021) Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality. Journal of Clinical Immunology 41:7, pages 1607-1620.
Crossref
Crossref
Yassine Taoufik, Marie-Ghislaine de Goër de Herve, Stéphanie Corgnac, Antoine Durrbach & Fathia Mami-Chouaib. (2021) When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak. Frontiers in Immunology 12.
Crossref
Crossref
Michael J. Christie, Aaron T. Irving, Samuel C. Forster, Benjamin J. MarslandPhilip M. Hansbro, Paul J. HertzogClaudia A. Nold-Petry & Marcel F. Nold. (2021) Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection. Science Immunology 6:63.
Crossref
Crossref
Konstantin Stark & Steffen Massberg. (2021) Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology 18:9, pages 666-682.
Crossref
Crossref
Yahui Wen, Feiyan Shen & Haibin Wu. (2021) Role of C5a and C5aR in doxorubicin‑induced cardiomyocyte senescence. Experimental and Therapeutic Medicine 22:4.
Crossref
Crossref
Anita Gupta & G. S. Gupta. (2021) Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs. Molecular and Cellular Biochemistry 476:8, pages 2917-2942.
Crossref
Crossref
Menizibeya O. Welcome & Nikos E. Mastorakis. (2021) Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology 29:4, pages 939-963.
Crossref
Crossref
Hongbin Wang & Mengyao Liu. (2021) Complement C4, Infections, and Autoimmune Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Bandar Alosaimi, Ayman Mubarak, Maaweya E. Hamed, Abdullah Z. Almutairi, Ahmed A. Alrashed, Abdullah AlJuryyan, Mushira Enani, Faris Q. Alenzi & Wael Alturaiki. (2021) Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Frontiers in Immunology 12.
Crossref
Crossref
Nuno Brito Santos, Zoé Enderlin Vaz da Silva, Catarina Gomes, Celso A. Reis & Maria João Amorim. (2021) Complement Decay-Accelerating Factor is a modulator of influenza A virus lung immunopathology. PLOS Pathogens 17:7, pages e1009381.
Crossref
Crossref
Sonata Jodele & Jörg Köhl. (2020) Tackling COVID‐19 infection through complement‐targeted immunotherapy. British Journal of Pharmacology 178:14, pages 2832-2848.
Crossref
Crossref
Athina Tampaki, Eleni Gavriilaki, Christos Varelas, Achilles Anagnostopoulos & Efthymia Vlachaki. (2021) Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing. Blood Reviews 48, pages 100805.
Crossref
Crossref
Raquel Ferrer-Oliveras, Manel Mendoza, Sira Capote, Laia Pratcorona, Enrique Esteve-Valverde, Lluis Cabero-Roura & Jaume Alijotas-Reig. (2021) Immunological and physiopathological approach of COVID-19 in pregnancy. Archives of Gynecology and Obstetrics 304:1, pages 39-57.
Crossref
Crossref
Nishant R. Tiwari, Sanat Phatak, Vivek R. Sharma & Sanjay K. Agarwal. (2021) COVID-19 and thrombotic microangiopathies. Thrombosis Research 202, pages 191-198.
Crossref
Crossref
Qin Li & Zi Chen. (2021) An update: the emerging evidence of complement involvement in COVID-19. Medical Microbiology and Immunology 210:2-3, pages 101-109.
Crossref
Crossref
Nicole Ng & Charles A. Powell. (2021) Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease. Journal of Clinical Medicine 10:10, pages 2188.
Crossref
Crossref
Brandon Bautista-Becerril, Rebeca Campi-Caballero, Samuel Sevilla-Fuentes, Laura M. Hernández-Regino, Alejandro Hanono, Al Flores-Bustamante, Julieta González-Flores, Carlos A. García-Ávila, Arnoldo Aquino-Gálvez, Manuel Castillejos-López, Armida Juárez-Cisneros & Angel Camarena. (2021) Immunothrombosis in COVID-19: Implications of Neutrophil Extracellular Traps. Biomolecules 11:5, pages 694.
Crossref
Crossref
Lazara Elena Santiesteban-Lores, Thais Akemi Amamura, Tiago Francisco da Silva, Leonardo Moura Midon, Milena Carvalho Carneiro, Lourdes Isaac & Lorena Bavia. (2021) A double edged-sword - The Complement System during SARS-CoV-2 infection. Life Sciences 272, pages 119245.
Crossref
Crossref
Eleni Gavriilaki, Panagiotis G. Asteris, Tasoula Touloumenidou, Evaggelia-Evdoxia Koravou, Maria Koutra, Penelope Georgia Papayanni, Vassiliki Karali, Apostolia Papalexandri, Christos Varelas, Fani Chatzopoulou, Maria Chatzidimitriou, Dimitrios Chatzidimitriou, Anastasia Veleni, Savvas Grigoriadis, Evdoxia Rapti, Diamantis Chloros, Ioannis Kioumis, Evaggelos Kaimakamis, Milly Bitzani, Dimitrios Boumpas, Argyris Tsantes, Damianos Sotiropoulos, Ioanna Sakellari, Ioannis G. Kalantzis, Stefanos T. Parastatidis, Mohammadreza Koopialipoor, Liborio Cavaleri, Danial J. Armaghani, Anastasia Papadopoulou, Robert Alan Brodsky, Styliani Kokoris & Achilles Anagnostopoulos. (2021) Genetic justification of severe COVID-19 using a rigorous algorithm. Clinical Immunology 226, pages 108726.
Crossref
Crossref
Kurt R. Stenmark, Maria G. Frid, Evgenia Gerasimovskaya, Hui Zhang, Mary K. McCarthy, Joshua M. Thurman & Thomas E. Morrison. (2021) Mechanisms of SARS‐CoV‐2‐induced lung vascular disease: potential role of complement. Pulmonary Circulation 11:2, pages 1-14.
Crossref
Crossref
Peter Garred, Andrea J. Tenner & Tom E. Mollnes. (2021) Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics. Pharmacological Reviews 73:2, pages 792-827.
Crossref
Crossref
Mohammad A.M. Ali & Sarah A. Spinler. (2021) COVID-19 and thrombosis: From bench to bedside. Trends in Cardiovascular Medicine 31:3, pages 143-160.
Crossref
Crossref
Hamed Azhdari Tehrani, Maryam Darnahal, Mohammad Vaezi & Shirin Haghighi. (2021) COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review. International Immunopharmacology 93, pages 107397.
Crossref
Crossref
Komudi Singh, Yun-Ching Chen, Shahin Hassanzadeh, Kim Han, Jennifer T. Judy, Fayaz Seifuddin, Ilker Tunc, Michael N. Sack & Mehdi Pirooznia. (2021) Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection. Frontiers in Genetics 12.
Crossref
Crossref
Ana Marcos‐Jiménez, Santiago Sánchez‐Alonso, Ana Alcaraz‐Serna, Laura Esparcia, Celia López‐Sanz, Miguel Sampedro‐Núñez, Tamara Mateu‐Albero, Ildefonso Sánchez‐Cerrillo, Pedro Martínez‐Fleta, Ligia Gabrie, Luciana del Campo Guerola, José Miguel Rodríguez‐Frade, José M. Casasnovas, Hugh T. Reyburn, Mar Valés‐Gómez, Margarita López‐Trascasa, Enrique Martín‐Gayo, María José Calzada, Santos Castañeda, Hortensia de la Fuente, Isidoro González‐Álvaro, Francisco Sánchez‐Madrid, Cecilia Muñoz‐Calleja & Arantzazu Alfranca. (2021) Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients. European Journal of Immunology 51:3, pages 634-647.
Crossref
Crossref
Sabina Karim, Amin Islam, Shafquat Rafiq & Ismail Laher. (2021) The COVID-19 Pandemic: Disproportionate Thrombotic Tendency and Management Recommendations. Tropical Medicine and Infectious Disease 6:1, pages 26.
Crossref
Crossref
Aline H de Nooijer, Inge Grondman, Nico A F Janssen, Mihai G Netea, Loek Willems, Frank L van de Veerdonk, Evangelos J Giamarellos-Bourboulis, Erik J M Toonen, Leo A B Joosten, Martin Jaeger, Helga Dijkstra, Heidi Lemmers, Liesbeth van Emst, Kiki Schraa, Cor Jacobs, Anneke Hijmans, Trees Jansen, Fieke Weren, Liz Fransman, Jelle Gerretsen, Josephine van de Maat, Gerine Nijman, Simone Moorlag, Esther Taks, Priya Debisarun, Ilse Kouijzer, Heiman Wertheim, Joost Hopman, Janette Rahamat-Langendoen, Chantal Bleeker-Rovers, Jaap ten Oever, Reinout van Crevel, Jacobien Hoogerwerf, Quirijn de Mast, Hans van der Hoeven, Peter Pickkers, Matthijs Kox, Tim Frenzel, Jeroen Schouten, Pleun Hemelaar, Remi Beunders, Sjef van der Velde, Emma Kooistra, Nicole Waalders, Wout Claassen, Hidde Heesakkers, Tirsa van Schaik, Hetty van der Eng, Noortje Rovers & Margreet Klop-Riehl. (2021) Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes. The Journal of Infectious Diseases 223:2, pages 214-224.
Crossref
Crossref
Faraz Alizadeh, Amanda O’Halloran, Areej Alghamdi, Charlotte Chen, Maria Trissal, Avram Traum & Danielle DeCourcey. (2021) Toddler With New Onset Diabetes and Atypical Hemolytic-Uremic Syndrome in the Setting of COVID-19. Pediatrics 147:2.
Crossref
Crossref
Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta & Ishmael Jaiyesimi. (2021) Hematologic disorders associated with COVID-19: a review. Annals of Hematology 100:2, pages 309-320.
Crossref
Crossref
Nicholas A. Wong & Milton H. SaierJr.Jr.. (2021) The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis. International Journal of Molecular Sciences 22:3, pages 1308.
Crossref
Crossref
Hau C. Kwaan & Paul F. Lindholm. (2021) The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective. International Journal of Molecular Sciences 22:3, pages 1283.
Crossref
Crossref
Valéria Bumiller-Bini, Camila de Freitas Oliveira-Toré, Tamyres Mingorance Carvalho, Gabriela Canalli Kretzschmar, Letícia Boslooper Gonçalves, Nina de Moura Alencar, Miguel Angelo Gasparetto Filho, Marcia Holsbach Beltrame & Angelica Beate Winter Boldt. (2021) MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genetics and Molecular Biology 44:1 suppl 1.
Crossref
Crossref
Rohit S. Loomba, Gaurav Aggarwal, Enrique G. Villarreal, Juan S. Farias, Saul Flores, Carl J. Lavie & Saurabh Aggarwal. (2021) Factors associated with deep venous thrombosis in patients infected with coronavirus disease 2019: a meta-analysis. Blood Coagulation & Fibrinolysis 32:1, pages 23-28.
Crossref
Crossref
Joris R. Delanghe, Marc L. De Buyzere & Marijn M. Speeckaert. 2021. Coronavirus Disease - COVID-19. Coronavirus Disease - COVID-19
109
118
.
Caroline Diorio, Kevin O. McNerney, Michele Lambert, Michele Paessler, Elizabeth M. Anderson, Sarah E. HenricksonJulie ChaseEmily J. LieblingChakkapong BurudpakdeeJessica H. LeeFrances B. BalamuthAllison M. Blatz, Kathleen ChiotosJulie C. FitzgeraldTherese M. Giglia, Kandace GollompAudrey R. Odom JohnCristina Jasen, Tomas Leng, Whitney PetrosaLaura A. Vella, Char WitmerKathleen E. SullivanBenjamin L. Laskin, Scott E. Hensley, Hamid Bassiri, Edward M. BehrensDavid T. Teachey. (2020) Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Advances 4:23, pages 6051-6063.
Crossref
Crossref
Sammy Al‐Benna. (2020) Pathophysiology of coronavirus disease 2019 for wound care professionals. International Wound Journal 17:6, pages 1935-1940.
Crossref
Crossref
Alexander P J Vlaar, Sanne de Bruin, Matthias Busch, Sjoerd A M E G Timmermans, Ingeborg E van Zeggeren, Rutger Koning, Liora ter Horst, Esther B Bulle, Frank E H P van Baarle, Marcel C G van de Poll, E Marleen Kemper, Iwan C C van der Horst, Marcus J Schultz, Janneke Horn, Frederique Paulus, Lieuwe D Bos, W Joost Wiersinga, Martin Witzenrath, Simon Rueckinger, Korinna Pilz, Matthijs C Brouwer, Ren-Feng Guo, Leo Heunks, Pieter van Paassen, Niels C Riedemann & Diederik van de Beek. (2020) Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial. The Lancet Rheumatology 2:12, pages e764-e773.
Crossref
Crossref
Natella Maglakelidze, Kristen M. Manto & Timothy J. Craig. (2020) A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?. Pulmonary Therapy 6:2, pages 169-176.
Crossref
Crossref
Edward M. Conway & Edward L.G. Pryzdial. (2020) Is the COVID‐19 thrombotic catastrophe complement‐connected?. Journal of Thrombosis and Haemostasis 18:11, pages 2812-2822.
Crossref
Crossref
M.D. Johansen, A. Irving, X. Montagutelli, M.D. Tate, I. Rudloff, M.F. Nold, N.G. Hansbro, R.Y. Kim, C. Donovan, G. Liu, A. Faiz, K.R. Short, J.G. Lyons, G.W. McCaughan, M.D. Gorrell, A. Cole, C. Moreno, D. Couteur, D. Hesselson, J. Triccas, G.G. Neely, J.R. Gamble, S.J. Simpson, B.M. Saunders, B.G. Oliver, W.J. Britton, P.A. Wark, C.A. Nold-Petry & P.M. Hansbro. (2020) Animal and translational models of SARS-CoV-2 infection and COVID-19. Mucosal Immunology 13:6, pages 877-891.
Crossref
Crossref
Edem Gavor, Yeu Khai Choong, Shi Yin Er, Hariharan Sivaraman & J. Sivaraman. (2020) Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions. Trends in Immunology 41:11, pages 1006-1022.
Crossref
Crossref
Alessandro Rambaldi, Giuseppe Gritti, Maria Caterina Micò, Marco Frigeni, Gianmaria Borleri, Anna Salvi, Francesco Landi, Chiara Pavoni, Aurelio Sonzogni, Andrea Gianatti, Francesca Binda, Stefano Fagiuoli, Fabiano Di Marco, Luca Lorini, Giuseppe Remuzzi, Steve Whitaker & Gregory Demopulos. (2020) Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab. Immunobiology 225:6, pages 152001.
Crossref
Crossref
Djillali Annane, Nicholas Heming, Lamiae Grimaldi-Bensouda, Véronique Frémeaux-Bacchi, Marie Vigan, Anne-Laure Roux, Armance Marchal, Hugues Michelon, Martin Rottman & Pierre Moine. (2020) Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study. EClinicalMedicine 28, pages 100590.
Crossref
Crossref
Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein & Robert A. Brodsky. (2020) Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 136:18, pages 2080-2089.
Crossref
Crossref
Jan C. Holter, Soeren E. Pischke, Eline de BoerAndreas Lind, Synne Jenum, Aleksander R. Holten, Kristian TonbyAndreas Barratt-Due, Marina Sokolova, Camilla SchjalmViktoriia ChabanAnette KolderupTrung TranTorleif Tollefsrud GjølbergLinda G. SkeieLiv Hesstvedt, Vidar Ormåsen, Børre Fevang, Cathrine AustadKarl Erik Müller, Cathrine FladebyMona Holberg-PetersenBente HalvorsenFredrik Müller, Pål Aukrust, Susanne Dudman, Thor UelandJan Terje AndersenFridtjof Lund-JohansenLars Heggelund, Anne M. Dyrhol-RiiseTom E. Mollnes. (2020) Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proceedings of the National Academy of Sciences 117:40, pages 25018-25025.
Crossref
Crossref
Mouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah & Lalitha Nayak. (2020) The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thrombosis Research 194, pages 101-115.
Crossref
Crossref
Alexander Fletcher-Sandersjöö & Bo-Michael Bellander. (2020) Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review. Thrombosis Research 194, pages 36-41.
Crossref
Crossref
Jeffrey Laurence, J. Justin Mulvey, Madhav Seshadri, Alexandra Racanelli, Joanna Harp, Edward J. Schenck, Dana Zappetti, Evelyn M. Horn & Cynthia M. Magro. (2020) Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19. Clinical Immunology 219, pages 108555.
Crossref
Crossref
Ludmila Lupu, Annette Palmer & Markus Huber-Lang. (2020) Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS. Frontiers in Immunology 11.
Crossref
Crossref
Martin W. Lo, Claudia Kemper & Trent M. Woodruff. (2020) COVID-19: Complement, Coagulation, and Collateral Damage. The Journal of Immunology 205:6, pages 1488-1495.
Crossref
Crossref
Courtney M. Campbell, Avirup Guha, Tamanna Haque, Tomas G. Neilan & Daniel Addison. (2020) Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review. Journal of Clinical Medicine 9:9, pages 2935.
Crossref
Crossref
Emilia Sinderewicz, Wioleta Czelejewska, Katarzyna Jezierska-Wozniak, Joanna Staszkiewicz-Chodor & Wojciech Maksymowicz. (2020) Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?. Pathogens 9:9, pages 739.
Crossref
Crossref
Nigel MackmanSilvio AntoniakAlisa S. WolbergRaj KasthuriNigel S. Key. (2020) Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arteriosclerosis, Thrombosis, and Vascular Biology 40:9, pages 2033-2044.
Crossref
Crossref
Wei Shi, Jiagao Lv & Li Lin. (2020) Coagulopathy in COVID-19: Focus on vascular thrombotic events. Journal of Molecular and Cellular Cardiology 146, pages 32-40.
Crossref
Crossref
Yingyang Xu, Shuang Liu, Yan Zhang & Yuxiang Zhi. (2020) Does hereditary angioedema make COVID-19 worse?. World Allergy Organization Journal 13:9, pages 100454.
Crossref
Crossref
Giuseppe Magro. (2020) COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. Virus Research 286, pages 198070.
Crossref
Crossref
Baranca Buijsers, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast & Johan van der Vlag. (2020) Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. eBioMedicine 59, pages 102969.
Crossref
Crossref
Nirupa Gadi, Samantha C. Wu, Allison P. Spihlman & Vaishali R. Moulton. (2020) What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses. Frontiers in Immunology 11.
Crossref
Crossref
Hanaa Ahmed-Hassan, Brianna Sisson, Rajni Kant Shukla, Yasasvi Wijewantha, Nicholas T. Funderburg, Zihai Li, Don HayesJr.Jr., Thorsten Demberg & Namal P. M. Liyanage. (2020) Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Frontiers in Immunology 11.
Crossref
Crossref
Pascal Urwyler, Stephan Moser, Panteleimon Charitos, Ingmar A. F. M. Heijnen, Melanie Rudin, Gregor Sommer, Bruno M. Giannetti, Stefano Bassetti, Parham Sendi, Marten Trendelenburg & Michael Osthoff. (2020) Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System. Frontiers in Immunology 11.
Crossref
Crossref
Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, Linda S Klavinskis & Steven Sacks. (2020) Rationale for targeting complement in COVID‐19. EMBO Molecular Medicine 12:8.
Crossref
Crossref
Austin G. Kulasekararaj, Ioanna Lazana, Joanna Large, Kristina Posadas, Helen Eagleton, John Lord Villajin, Mark Zuckerman, Shreyans Gandhi & Judith C. W. Marsh. (2020) Terminal complement inhibition dampens the inflammation during COVID‐19. British Journal of Haematology 190:3.
Crossref
Crossref
Marina Noris, Ariela Benigni & Giuseppe Remuzzi. (2020) The case of complement activation in COVID-19 multiorgan impact. Kidney International 98:2, pages 314-322.
Crossref
Crossref
Markus Bosmann. (2020) Complement Activation during Critical Illness: Current Findings and an Outlook in the Era of COVID-19. American Journal of Respiratory and Critical Care Medicine 202:2, pages 163-165.
Crossref
Crossref
Jack Mellors, Tom Tipton, Stephanie Longet & Miles Carroll. (2020) Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics. Frontiers in Immunology 11.
Crossref
Crossref
Philip F. Stahel & Scott R. Barnum. (2020) Complement Inhibition in Coronavirus Disease (COVID)-19: A Neglected Therapeutic Option. Frontiers in Immunology 11.
Crossref
Crossref
Bo Shen, Xiao Yi, Yaoting Sun, Xiaojie Bi, Juping Du, Chao Zhang, Sheng Quan, Fangfei Zhang, Rui Sun, Liujia Qian, Weigang Ge, Wei Liu, Shuang Liang, Hao Chen, Ying Zhang, Jun Li, Jiaqin Xu, Zebao He, Baofu Chen, Jing Wang, Haixi Yan, Yufen Zheng, Donglian Wang, Jiansheng Zhu, Ziqing Kong, Zhouyang Kang, Xiao Liang, Xuan Ding, Guan Ruan, Nan Xiang, Xue Cai, Huanhuan Gao, Lu Li, Sainan Li, Qi Xiao, Tian Lu, Yi Zhu, Huafen Liu, Haixiao Chen & Tiannan Guo. (2020) Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell 182:1, pages 59-72.e15.
Crossref
Crossref
Courtney M. CampbellRami Kahwash. (2020) Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?. Circulation 141:22, pages 1739-1741.
Crossref
Crossref
Eleni Gavriilaki & Robert A. Brodsky. (2020) Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily. British Journal of Haematology 189:6.
Crossref
Crossref
Sara Mastaglio, Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos, Markus Huber-Lang, Simona Piemontese, Andrea Assanelli, Cecilia Garlanda, John D. Lambris & Fabio Ciceri. (2020) The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clinical Immunology 215, pages 108450.
Crossref
Crossref
Eleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki & Achilles Anagnostopoulos. (2020) A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity. International Journal of Molecular Sciences 21:11, pages 3886.
Crossref
Crossref
Jean-Michel Sallenave & Loïc Guillot. (2020) Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?. Frontiers in Immunology 11.
Crossref
Crossref
Maha Saber-Ayad, Mohamed A. Saleh & Eman Abu-Gharbieh. (2020) The Rationale for Potential Pharmacotherapy of COVID-19. Pharmaceuticals 13:5, pages 96.
Crossref
Crossref
Luca Quartuccio, Luca Semerano, Maurizio Benucci, Marie-Christophe Boissier & Salvatore De Vita. (2020) Pistes urgentes dans le traitement de l’infection par le COVID-19 : cibler l’inflammation en aval pour prévenir un syndrome catastrophique. Revue du Rhumatisme 87:3, pages 146-149.
Crossref
Crossref
Luca Quartuccio, Luca Semerano, Maurizio Benucci, Marie-Christophe Boissier & Salvatore De Vita. (2020) Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome. Joint Bone Spine 87:3, pages 191-193.
Crossref
Crossref
Meraj A. Khan, Zubair Sabz Ali, Neil Sweezey, Hartmut Grasemann & Nades Palaniyar. (2019) Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation. Genes 10:3, pages 183.
Crossref
Crossref
Yuting Jiang, Junfeng Li, Yue Teng, Hong Sun, Guang Tian, Lei He, Pei Li, Yuehong Chen, Yan Guo, Jiangfan Li, Guangyu Zhao, Yusen Zhou & Shihui Sun. (2019) Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV. Viruses 11:1, pages 39.
Crossref
Crossref
Lisa E. Gralinski, Timothy P. Sheahan, Thomas E. Morrison, Vineet D. Menachery, Kara Jensen, Sarah R. Leist, Alan Whitmore, Mark T. Heise & Ralph S. Baric. (2018) Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio 9:5.
Crossref
Crossref
Hongbo Chi, Kai Zhou, Liping Shen, Jiaqin Xu, Jun Li, Shiyong Chen, Xiaomai Wu, Tao-Hsin Tung, Bo Shen & Hongguo Zhu. (2022) The Evaluation of the Immune Status of COVID-19 Recovered Subjects with Persistent Abnormal Lung CT after One Year: A Longitudinal Cohort Study. SSRN Electronic Journal.
Crossref
Crossref